v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Preferred stock
Common stock
Additional paid-in Capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2024   2,369,797        
Beginning balance at Dec. 31, 2024 $ 754,383 $ 0 $ 2 $ 2,556,095 $ 468 $ (1,802,182)
Beginning balance (in shares) at Dec. 31, 2024     22,004,679      
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock under equity plans (in shares)     183,037      
Issuance of common stock under equity plans 8,640     8,640    
Stock-based compensation expense related to equity-classified awards 20,931     20,931    
Other comprehensive income (loss) (79)       (79)  
Net income (loss) (73,238)         (73,238)
Ending balance (in shares) at Mar. 31, 2025   2,369,797        
Ending balance at Mar. 31, 2025 710,637 $ 0 $ 2 2,585,666 389 (1,875,420)
Ending balance (in shares) at Mar. 31, 2025     22,187,716      
Beginning balance (in shares) at Dec. 31, 2024   2,369,797        
Beginning balance at Dec. 31, 2024 754,383 $ 0 $ 2 2,556,095 468 (1,802,182)
Beginning balance (in shares) at Dec. 31, 2024     22,004,679      
Increase (Decrease) in Stockholders' Equity            
Other comprehensive income (loss) 600          
Net income (loss) (229,709)          
Ending balance (in shares) at Sep. 30, 2025   2,369,797        
Ending balance at Sep. 30, 2025 625,732 $ 0 $ 2 2,656,553 1,068 (2,031,891)
Ending balance (in shares) at Sep. 30, 2025     22,704,303      
Beginning balance (in shares) at Mar. 31, 2025   2,369,797        
Beginning balance at Mar. 31, 2025 710,637 $ 0 $ 2 2,585,666 389 (1,875,420)
Beginning balance (in shares) at Mar. 31, 2025     22,187,716      
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock under equity plans (in shares)     33,400      
Issuance of common stock under equity plans 1,741     1,741    
Stock-based compensation expense related to equity-classified awards 25,159     25,159    
Other comprehensive income (loss) 722       722  
Net income (loss) (42,281)         (42,281)
Ending balance (in shares) at Jun. 30, 2025   2,369,797        
Ending balance at Jun. 30, 2025 695,978 $ 0 $ 2 2,612,566 1,111 (1,917,701)
Ending balance (in shares) at Jun. 30, 2025     22,221,116      
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock under equity plans (in shares)     483,187      
Issuance of common stock under equity plans 17,735     17,735    
Stock-based compensation expense related to equity-classified awards 26,252     26,252    
Other comprehensive income (loss) (43)       (43)  
Net income (loss) (114,190)         (114,190)
Ending balance (in shares) at Sep. 30, 2025   2,369,797        
Ending balance at Sep. 30, 2025 $ 625,732 $ 0 $ 2 2,656,553 1,068 (2,031,891)
Ending balance (in shares) at Sep. 30, 2025     22,704,303      
Beginning balance (in shares) at Dec. 31, 2025 2,369,797 2,369,797        
Beginning balance at Dec. 31, 2025 $ 602,689 $ 0 $ 2 2,692,280 873 (2,090,466)
Beginning balance (in shares) at Dec. 31, 2025 22,842,073   22,842,073      
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock under equity plans (in shares)     199,845      
Issuance of common stock under equity plans $ 2,329     2,329    
Stock-based compensation expense related to equity-classified awards 32,618     32,618    
Other comprehensive income (loss) 209       209  
Net income (loss) (94,391)         (94,391)
Ending balance (in shares) at Mar. 31, 2026   2,369,797        
Ending balance at Mar. 31, 2026 $ 543,454 $ 0 $ 2 2,727,227 1,082 (2,184,857)
Ending balance (in shares) at Mar. 31, 2026     23,041,918      
Beginning balance (in shares) at Dec. 31, 2025 2,369,797 2,369,797        
Beginning balance at Dec. 31, 2025 $ 602,689 $ 0 $ 2 2,692,280 873 (2,090,466)
Beginning balance (in shares) at Dec. 31, 2025 22,842,073   22,842,073      
Increase (Decrease) in Stockholders' Equity            
Other comprehensive income (loss) $ (2,602)          
Net income (loss) $ (96,888)          
Ending balance (in shares) at Sep. 30, 2026 2,369,797 2,369,797        
Ending balance at Sep. 30, 2026 $ 626,941 $ 0 $ 2 2,816,022 (1,729) (2,187,354)
Ending balance (in shares) at Sep. 30, 2026 23,221,744   23,221,744      
Beginning balance (in shares) at Mar. 31, 2026   2,369,797        
Beginning balance at Mar. 31, 2026 $ 543,454 $ 0 $ 2 2,727,227 1,082 (2,184,857)
Beginning balance (in shares) at Mar. 31, 2026     23,041,918      
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock under equity plans (in shares)     52,056      
Issuance of common stock under equity plans 3,112     3,112    
Stock-based compensation expense related to equity-classified awards 35,371     35,371    
Other comprehensive income (loss) (274)       (274)  
Net income (loss) (57,939)         (57,939)
Ending balance (in shares) at Jun. 30, 2026   2,369,797        
Ending balance at Jun. 30, 2026 523,724 $ 0 $ 2 2,765,710 808 (2,242,796)
Ending balance (in shares) at Jun. 30, 2026     23,093,974      
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock under equity plans (in shares)     127,770      
Issuance of common stock under equity plans 9,965     9,965    
Stock-based compensation expense related to equity-classified awards 40,347     40,347    
Other comprehensive income (loss) (2,537)       (2,537)  
Net income (loss) $ 55,442         55,442
Ending balance (in shares) at Sep. 30, 2026 2,369,797 2,369,797        
Ending balance at Sep. 30, 2026 $ 626,941 $ 0 $ 2 $ 2,816,022 $ (1,729) $ (2,187,354)
Ending balance (in shares) at Sep. 30, 2026 23,221,744   23,221,744